[1]
Sakkiah, S.; Cao, G.P.; Gupta, S.P.; Seok Ju Park, S.J.; Keun, Woo Lee K.W. Overview of the structure and function of protein kinases. Curr. Enzym. Inhib., 2017, 13, 81-88.
[2]
Gupta, S.P.; Shaik, B.; Vijay, K.; Agrawal, V.K. Specificity of binding in protein kinases. Curr. Enz. Inhib., 2017, 13, 89-98.
[3]
Kini, S.G.; Garg, V.; Prasanna, S.; Rajappan, R.; Muhammad Mubeen, M. Protein kinases as drug targets in human and animal diseases. Curr. Enz. Inhib., 2017, 13, 99-106.
[4]
Shah, D.B.; Ramanathan, M. Glycogen synthase kinase-3: A potential target for drug discovery in the treatment of neurodegenerative disorders. Curr. Enz. Inhib., 2017, 13, 107-128.
[5]
Lupino, E.; Piccinini, M. The polyhedric Abl kinases and their pharmacologic inhibitors. Curr. Enz. Inhib., 2017, 13, 129-138.
[6]
Patil, V.M.; Gupta, S.P.; Masand, N. Quantitative structure-activity relationship studies on tyrosine kinase inhibitors. Curr. Enz. Inhib., 2017, 13, 139-159.
[7]
Knighton, D.R.; Zheng, J.H.; Ten Eyck, L.F.; Ashford, V.A.; Xuong, N.H.; Taylor, S.S.; Sowadski, J.M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science, 1991, 253, 407-414.
[8]
Shchemelinin, I.; Sefc, L.; Necas, E. Protein kinases, their function and implication in cancer and other diseases. Folia Biologica, 2006, 52, 81-100.
[9]
Nolen, B.; Taylor, S.; Ghosh, G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol. Cell, 2004, 15, 661-675.
[10]
Cowan-Jacob, S.W.; Moebitz, H.; Fabbro, D. Structural biology contributions to tyrosine kinase drug discovery. Curr. Opin. Cell Biol., 2009, 21, 280-287.
[11]
Ferrer, I.; Barrachina, M.; Puig, B. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer’s disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol., 2002, 104, 583-591.
[12]
Eldar-Finkelman, H. Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol. Med., 2002, 8, 126-132.
[13]
Silberman, I.; Sionov, R.V.; Zuckerman, V.; Haupt, S.; Goldberg, Z.; Strasser, A.; Ben-Sasson, Z.S.; Baniyash, M.; Koleske, A.J.; Haupt, Y. T cell survival and function requires the c-Abl tyrosine kinase. Cell Cycle, 2008, 7, 3847-3857.
[14]
Huang, Y.; Comiskey, E.O.; Dupree, R.S.; Li, S.; Koleske, A.J.; Burkhardt, J.K. 2008. The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse. Blood, 2008, 112, 111-119.
[15]
Gu, J.J.; Ryu, J.R.; Pendergast, A.M. Abl tyrosine kinases in T-cell signaling. Immunol. Rev., 2009, 228, 170-183.
[16]
Krause, D.S.; Van Etten, R.A. Tyrosine kinases as targets for cancer therapy. The New. Engl. J. Med., 2005, 353, 172-187.
Related Books
Aromatherapy: The Science of Essential Oils
In Vitro Propagation and Secondary Metabolite Production from Medicinal Plants: Current Trends (Part 2)
Micropropagation of Medicinal Plants
Software and Programming Tools in Pharmaceutical Research
Biotechnology and Drug Development for Targeting Human Diseases
In Vitro Propagation and Secondary Metabolite Production from Medicinal Plants: Current Trends (Part 1)
Molecular and Physiological Insights into Plant Stress Tolerance and Applications in Agriculture- Part 2
Micropropagation of Medicinal Plants
Genome Editing in Bacteria (Part 1)
Data Science for Agricultural Innovation and Productivity
Article Metrics
53
4